136 related articles for article (PubMed ID: 34905170)
1. Purification of HLA Immunopeptidomes from Human Thymus.
Alvarez I
Methods Mol Biol; 2022; 2420():127-136. PubMed ID: 34905170
[TBL] [Abstract][Full Text] [Related]
2. HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy.
Marcu A; Bichmann L; Kuchenbecker L; Kowalewski DJ; Freudenmann LK; Backert L; Mühlenbruch L; Szolek A; Lübke M; Wagner P; Engler T; Matovina S; Wang J; Hauri-Hohl M; Martin R; Kapolou K; Walz JS; Velz J; Moch H; Regli L; Silginer M; Weller M; Löffler MW; Erhard F; Schlosser A; Kohlbacher O; Stevanović S; Rammensee HG; Neidert MC
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33858848
[TBL] [Abstract][Full Text] [Related]
3. Distinguishing Signal From Noise in Immunopeptidome Studies of Limiting-Abundance Biological Samples: Peptides Presented by I-A
Nanaware PP; Jurewicz MM; Clement CC; Lu L; Santambrogio L; Stern LJ
Front Immunol; 2021; 12():658601. PubMed ID: 33995376
[TBL] [Abstract][Full Text] [Related]
4. Composition of the HLA-DR-associated human thymus peptidome.
Collado JA; Alvarez I; Ciudad MT; Espinosa G; Canals F; Pujol-Borrell R; Carrascal M; Abian J; Jaraquemada D
Eur J Immunol; 2013 Sep; 43(9):2273-82. PubMed ID: 23719902
[TBL] [Abstract][Full Text] [Related]
5. Soluble HLA peptidome of pleural effusions is a valuable source for tumor antigens.
Khazan-Kost S; Cafri G; Melamed Kadosh D; Mooshayef N; Chatterji S; Dominissini D; Manor S; Zisser B; Broday L; Talalai E; Shemer A; Zadok O; Ofek E; Onn A; Admon A; Peled M
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580925
[TBL] [Abstract][Full Text] [Related]
6. Immunopeptidomic Analysis of the Phosphopeptidome Displayed by HLA Class I Molecules.
Marcilla M
Methods Mol Biol; 2022; 2420():149-158. PubMed ID: 34905172
[TBL] [Abstract][Full Text] [Related]
7. Peptidomes and Structures Illustrate Two Distinguishing Mechanisms of Alternating the Peptide Plasticity Caused by Swine MHC Class I Micropolymorphism.
Wei X; Wang S; Li Z; Li Z; Qu Z; Wang S; Zou B; Liang R; Xia C; Zhang N
Front Immunol; 2021; 12():592447. PubMed ID: 33717070
[TBL] [Abstract][Full Text] [Related]
8. PRBAM: a new tool to analyze the MHC class I and HLA-DR anchor motifs.
Mestre-Ferrer A; Scholz E; Humet-Alsius J; Alvarez I
Immunology; 2019 Feb; 156(2):187-198. PubMed ID: 30408168
[TBL] [Abstract][Full Text] [Related]
9. Guidance Document: Validation of a High-Performance Liquid Chromatography-Tandem Mass Spectrometry Immunopeptidomics Assay for the Identification of HLA Class I Ligands Suitable for Pharmaceutical Therapies.
Ghosh M; Gauger M; Marcu A; Nelde A; Denk M; Schuster H; Rammensee HG; Stevanović S
Mol Cell Proteomics; 2020 Mar; 19(3):432-443. PubMed ID: 31937595
[TBL] [Abstract][Full Text] [Related]
10. Protocol for purification and identification of MHC class I immunopeptidome from cancer cell lines.
Mohan SV; Datta KK; Ziegman R; Smith C; Gowda H
STAR Protoc; 2021 Mar; 2(1):100385. PubMed ID: 33778779
[TBL] [Abstract][Full Text] [Related]
11. Class II MHC self-antigen presentation in human B and T lymphocytes.
Costantino CM; Spooner E; Ploegh HL; Hafler DA
PLoS One; 2012; 7(1):e29805. PubMed ID: 22299025
[TBL] [Abstract][Full Text] [Related]
12. Generation of HLA Allele-Specific Spectral Libraries to Identify and Quantify Immunopeptidomes by SWATH/DIA-MS.
Kovalchik K; Hamelin D; Caron E
Methods Mol Biol; 2022; 2420():137-147. PubMed ID: 34905171
[TBL] [Abstract][Full Text] [Related]
13. HLA class II immunopeptidomics reveals that co-inherited HLA-allotypes within an extended haplotype can improve proteome coverage for immunosurveillance.
Ramarathinam SH; Ho BK; Dudek NL; Purcell AW
Proteomics; 2021 Sep; 21(17-18):e2000160. PubMed ID: 34357683
[TBL] [Abstract][Full Text] [Related]
14. Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma.
Shraibman B; Barnea E; Kadosh DM; Haimovich Y; Slobodin G; Rosner I; López-Larrea C; Hilf N; Kuttruff S; Song C; Britten C; Castle J; Kreiter S; Frenzel K; Tatagiba M; Tabatabai G; Dietrich PY; Dutoit V; Wick W; Platten M; Winkler F; von Deimling A; Kroep J; Sahuquillo J; Martinez-Ricarte F; Rodon J; Lassen U; Ottensmeier C; van der Burg SH; Thor Straten P; Poulsen HS; Ponsati B; Okada H; Rammensee HG; Sahin U; Singh H; Admon A
Mol Cell Proteomics; 2019 Jun; 18(6):1255-1268. PubMed ID: 31154438
[TBL] [Abstract][Full Text] [Related]
15. Optimized Liquid and Gas Phase Fractionation Increases HLA-Peptidome Coverage for Primary Cell and Tissue Samples.
Klaeger S; Apffel A; Clauser KR; Sarkizova S; Oliveira G; Rachimi S; Le PM; Tarren A; Chea V; Abelin JG; Braun DA; Ott PA; Keshishian H; Hacohen N; Keskin DB; Wu CJ; Carr SA
Mol Cell Proteomics; 2021; 20():100133. PubMed ID: 34391888
[TBL] [Abstract][Full Text] [Related]
16. Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients.
Chornoguz O; Gapeev A; O'Neill MC; Ostrand-Rosenberg S
Mol Cell Proteomics; 2012 Nov; 11(11):1457-67. PubMed ID: 22942358
[TBL] [Abstract][Full Text] [Related]
17. Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma.
Shraibman B; Barnea E; Kadosh DM; Haimovich Y; Slobodin G; Rosner I; López-Larrea C; Hilf N; Kuttruff S; Song C; Britten C; Castle J; Kreiter S; Frenzel K; Tatagiba M; Tabatabai G; Dietrich PY; Dutoit V; Wick W; Platten M; Winkler F; von Deimling A; Kroep J; Sahuquillo J; Martinez-Ricarte F; Rodon J; Lassen U; Ottensmeier C; van der Burg SH; Thor Straten P; Poulsen HS; Ponsati B; Okada H; Rammensee HG; Sahin U; Singh H; Admon A
Mol Cell Proteomics; 2018 Nov; 17(11):2132-2145. PubMed ID: 30072578
[TBL] [Abstract][Full Text] [Related]
18. Identification of Immunodominant HIV-1 Epitopes Presented by HLA-C*12:02, a Protective Allele, Using an Immunopeptidomics Approach.
Chikata T; Paes W; Akahoshi T; Partridge T; Murakoshi H; Gatanaga H; Ternette N; Oka S; Borrow P; Takiguchi M
J Virol; 2019 Sep; 93(17):. PubMed ID: 31217245
[TBL] [Abstract][Full Text] [Related]
19. Isolation of HLA Bound Peptides by Immunoaffinity Capture and Identification by Mass Spectrometry.
Pandey K; Ramarathinam SH; Purcell AW
Curr Protoc; 2021 Mar; 1(3):e92. PubMed ID: 33769717
[TBL] [Abstract][Full Text] [Related]
20. Defining the HLA class I-associated viral antigen repertoire from HIV-1-infected human cells.
Ternette N; Yang H; Partridge T; Llano A; Cedeño S; Fischer R; Charles PD; Dudek NL; Mothe B; Crespo M; Fischer WM; Korber BT; Nielsen M; Borrow P; Purcell AW; Brander C; Dorrell L; Kessler BM; Hanke T
Eur J Immunol; 2016 Jan; 46(1):60-9. PubMed ID: 26467324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
